Liste des principales publications

2018

Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology. Rambeau A, Beauplet B, Laviec H, Licaj I, Leconte A, Chatel C, Le Bon P, Denhaerynck J, Clarisse B, Frenkiel N, Lange M, Joly F. J Geriatr Oncol. 2018 Aug 24. pii: S1879-4068(18)30095-X. doi: 10.1016/j.jgo.2018.08.003. [Epub ahead of print] PubMed PMID: 30150019

 

Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. Lange M, Heutte N, Noal S, Rigal O, Kurtz JE, Lévy C, Allouache D, Rieux C, Lefel J, Clarisse B, Leconte A, Veyret C, Barthélémy P, Longato N, Tron L, Castel H, Eustache F, Giffard B, Joly F. The Oncologist. 2018 Jun 22. pii: theoncologist.2017-0570. doi: 10.1634/theoncologist.2017-0570. [Epub ahead of print] PubMed PMID: 29934409.

 

 Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research. Winocur G, Johnston I, Castel H. Cancer Treat Rev. 2018 Jun 1;69:72-83. doi: 10.1016/j.ctrv.2018.05.017. [Epub ahead of print] Review. PubMed PMID: 29909223.

 

Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies. Denouel A, Heutte N, Escudier B, Kurtz JE, Santos MD, Longato N, Desrues L, Dauchy S, Lange M, Sevin E, Rieux C, Clarisse B, Castel H, Noal S, Joly F. Clin Genitourin Cancer.2018 May 21. pii:
S1558-7673(18)30286-6. doi: 10.1016/j.clgc.2018.05.013. [Epub ahead of print] PubMed PMID: 30007862.

2017

How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment. Lange M, Joly F. J Oncol Pract. 2017 Dec;13(12):784-790. doi:10.1200/JOP.2017.026286. PubMed PMID: 29232539.

 

Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. Lange M, Laviec H, Castel H, Heutte N, Leconte A, Leger I, et al. BMC Cancer. 2017;17(1):549.

 

Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors. Castel, H., Denouel, A., Lange, M., Tonon, M-C., Dubois, M., Joly, F. (2017).Frontiers in Pharmacology, 8: 138

 

Plaintes cognitives induites par les traitements en cancérologie. Lange, M., Léger, I. La lettre du Cancérologue Vol. XXVI – n° 4 – avril 2017

 

Cognitive complaints in breast cancer patients treated with chemotherapy: a reality? Lange M, Joly F. Transl Cancer Res 2017;6(Suppl 3):S461-S463. doi: 10.21037

 

2016

Decline in cognitive function in older adults with early-stage  breast cancer after adjuvant treatment. Lange M., Heutte N., Rigal O., Noal S, Kurtz J-E., Lévy C., Allouache D., Rieux C., Lefel J., Clarisse B., Veyret C., Barthélémy P., Longato N., Eustache F., Giffard B., Joly F. The Oncologist. 2016;  21(11), 1337-1348.

 

Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer. Joly F., Heutte N., Duclos B., Noal S., Léger I., Dauchy S., Longato N., Desrues L., Houédé N., Lange M., Sevin E., Rieux C., Clarisse B., Castel H., Escudier B. European Urology Focus. 2016, 2(6), 642-649http://dx.doi.org/10.1016/j.euf.2016.04.009

 

2015

Impact of cancer and treatments on cognitive functions: Advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since then. Joly F., Giffard B., Rigal O., De Ruiter M.B., Small B.J. Dubois M., LeFel J.,  Schagen S.B., Ahles T.A. Wefel J.S., Vardy J.L. Pancré V., Lange M., Castel H. J Pain Symptom Manage. 2015; 50(6), 830-841.

 

Emotional specificities of autobiographical memory after breast cancer diagnosis. Morel N., Dayan J., Piolino P., Viard A., Allouache D., Noal S., Levy C., Joly F., Eustache F., Giffard B. Consciousness and Cognition. 2015; 35, 42-52.

 

Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population. Lange M., Heutte N., Morel N., Eustache F., Joly F., Giffard B. Neuropsychol Rehabil. 2015, 7, 1-18.

 

Les troubles cognitifs légers liés au cancer : Comment et à quelles fins les évaluer en consultation neuropsychologique ? Giffard, B., Lange, M., Léger, L. Revue de neuropsychologie. 2015, 7(2), 127-134.

 

2014

Monitoring and optimising cognitive functioning cancer patients: Present knowledge and future directions. Schagen S.B., Klein M., Reijneveld J.C., Brain E., Deprez S., Joly F., Scherwath A., Schrauwen W., Wefel J.S.. EJC Supplements 2014: 29–40.

 

Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Lange M., Rigal O., Clarisse B., Giffard B., Sevin E., Barillet M., Eustache F., Joly F. Cancer Treatment Rev 2014 Jul; 40(6):810-7.

 

Baseline cognitive functions among elderly patients with localized breast cancer. Lange M., Giffard B., Noal S., Rigal O., Kurtz J-E., Heutte N., Lévy C., Allouache D., Rieux C., Lefel J., Daireaux A., Clarisse B., Veyret C., Barthélémy P., Longato N., Eustache F., Joly F. Eur J Cancer. 2014 Sep; 50(13):2181-9.

 

Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant. Dubois M., Lapinte N., Villier V., Lecointre C., Roy V., Tonon MC., Gandolfo P., Joly F., Hilber P., Castel H. Neuropharmacology. 2014; 79:234-48.

 

Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice. Dubois M., Le Joncour V., Tonon MC., Anouar Y., Proust F., Morin F., Gandolfo P., Joly F., Hilber P., Castel H. PLoS One. 2014;1;9-12.

 

2013

[Impact of cancer treatments on cognitive functions: the patients’ view, their expectation and their interest in participating to cognitive rehabilitation workshops]. Le Fel J., Daireaux A., Vandenbosshe S., Heutte N., Rigal O., Rovira K., Joly F,. Roy V. Bull Cancer. 2013 ;100 (3):223-9.

 

Autobiographical memory, self, and stress-related psychiatric disorders: which implications in cancer patients? Giffard B., Viard A., Dayan J., Morel N., Joly F., Eustache F. Neuropsychol Rev. 2013;23 157-68.

 

Impact of antiangiogenic treatment on cognitive functions and fatigue in metastatic renal cancer patients. Joly F., Noal S., Heutte N., Leger I., Duclos B., Lange M., Longato N., Dauchy S., Clarisse B., Escudier B. ESMO congress, Amsterdam sept 2013.

 

Une consultation mémoire en cancérologie : entre plainte et trouble… Léger I., de Batz L., Dauchy S. Psycho-Oncologie. 2013, 7, 210-216.

 

Synthesis, Biological Evaluation, and in Vivo Imaging of the first Camptothecin-Fluorescein Conjugate. Chevalier A., Dubois M., Le Joncour V., Dautrey S., Lecointre C., Romieu A., Renard PY., Castel H., Sabot C. Bioconjug Chem. 2013 Jun 24.

 

2012

French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Joly F., Lange M., Rigal O., Correia H., Giffard B., Beaumont JL., Clisant S., Wagner L. Support Care Cancer. 2012; 20:3297-305.

 

2011

Cognitive dysfunction and cancer: which consequences in terms of disease management? Joly F., Rigal O., Noal S., Giffard B. Psychooncology. 2011 Dec;20(12):1251-8.

 

One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Noal S., Levy C., Hardouin A., Rieux C., Heutte N., Ségura C., Collet F., Allouache D., Switsers O., Delcambre C., Delozier T., Henry-Amar M., Joly F. Int J Radiat Oncol Biol Phys. 2011 Nov 1; 81(3):795-803.

 

Impact de la chimiothérapie adjuvante dans le cancer du sein : revue de la littérature. Lange M., Giffard B., Eustache F., Morel N., Noal S. & Joly F. Psycho-oncologie, 2011; 5(1), 3-10.

 

2010

L’impact du cancer et de ses traitements sur les fonctions cognitives: l’exemple du cancer du sein. Morel N., Eustache F., Lange M., Joly F., Giffard B. Revue de neuropsychologie 2010: 2(3), 250 – 254.

 

2008

Fonctions cognitives et cancer. Joly.F. Bull Cancer 2008 ; 95 (11) : 1131-2